Cargando…

Outer Membrane Vesicles: An Emerging Vaccine Platform

Vaccine adjuvants are substances that improve the immune capacity of a recombinant vaccine to a great extent and have been in use since the early 1900s; they are primarily short-lived and initiate antigen activity, mainly an inflammatory response. With the developing technologies and innovation, ear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kashyap, Dharmendra, Panda, Mrutyunjaya, Baral, Budhadev, Varshney, Nidhi, R, Sajitha, Bhandari, Vasundhra, Parmar, Hamendra Singh, Prasad, Amit, Jha, Hem Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610665/ https://www.ncbi.nlm.nih.gov/pubmed/36298443 http://dx.doi.org/10.3390/vaccines10101578

Ejemplares similares

Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach
por: Sonkar, Charu, et al.
Publicado: (2020)

Comorbidity Assessment Is Essential During COVID-19 Treatment
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Data on differential pathogenic ability of Helicobacter pylori isolated from distinct gastric niches
por: Baral, Budhadev, et al.
Publicado: (2023)

Helicobacter pylori isolated from gastric juice have higher pathogenic potential than biopsy isolates
por: Baral, Budhadev, et al.
Publicado: (2023)

Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin
por: Kashyap, Dharmendra, et al.
Publicado: (2021)

Recent updates on COVID-19: A holistic review
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders
por: Kandpal, Meenakshi, et al.
Publicado: (2022)

Oral rinses in growth inhibition and treatment of Helicobacter pylori infection
por: Kashyap, Dharmendra, et al.
Publicado: (2020)

Mutational analysis of structural proteins of SARS-CoV-2
por: Jakhmola, Shweta, et al.
Publicado: (2021)

Potential entry receptors for human γ-herpesvirus into epithelial cells: A plausible therapeutic target for viral infections
por: Rani, Annu, et al.
Publicado: (2021)

Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations
por: Indari, Omkar, et al.
Publicado: (2021)

Outer membrane vesicles as platform vaccine technology
por: van der Pol, Leo, et al.
Publicado: (2015)

Protein-enriched outer membrane vesicles as a native platform for outer membrane protein studies
por: Thoma, Johannes, et al.
Publicado: (2018)

The interrelation of COVID-19 and neurological modalities
por: Jakhmola, Shweta, et al.
Publicado: (2021)

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines
por: Price, Nancy L., et al.
Publicado: (2016)

Bacterial outer membrane vesicles as a candidate tumor vaccine platform
por: Wang, Shuming, et al.
Publicado: (2022)

Effective Platform for the Production of Recombinant Outer Membrane Vesicles in Gram-Negative Bacteria
por: Kunjantarachot, Anthicha, et al.
Publicado: (2022)

Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment
por: Parmar, Hamendra Singh, et al.
Publicado: (2022)

mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine
por: Gao, Xiaoyu, et al.
Publicado: (2023)

Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine
por: Irene, Carmela, et al.
Publicado: (2019)

Proteome‐minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform
por: Zanella, Ilaria, et al.
Publicado: (2021)

A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens
por: Weyant, Kevin B., et al.
Publicado: (2023)

LDH as an adjuvant makes Brucella outer-membrane vesicles and outer-membrane vesicle-associated proteins highly protective in mice
por: Deng, Xiaoyu, et al.
Publicado: (2023)

Biomimetic Nanoparticles Coated with Bacterial Outer Membrane Vesicles as a New-Generation Platform for Biomedical Applications
por: Naskar, Atanu, et al.
Publicado: (2021)

Bacterial Outer Membrane Vesicles and Vaccine Applications
por: Acevedo, Reinaldo, et al.
Publicado: (2014)

Proteomics of Aggregatibacter actinomycetemcomitans Outer Membrane Vesicles
por: Kieselbach, Thomas, et al.
Publicado: (2015)

Outer membrane vesicle vaccines for Neisseria gonorrhoeae
por: Semchenko, Evgeny A., et al.
Publicado: (2021)

Gram-Negative Bacteria’s Outer Membrane Vesicles
por: Kim, Jeong Yeon, et al.
Publicado: (2023)

Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle‐based vaccine platform, for efficient viral antigen delivery
por: Hu, Kai, et al.
Publicado: (2022)

Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Protein A via Outer Membrane Vesicles
por: Jin, Jong Sook, et al.
Publicado: (2011)

The lethal cargo of Myxococcus xanthus outer membrane vesicles
por: Berleman, James E., et al.
Publicado: (2014)

Outer membrane vesicles – offensive weapons or good Samaritans?
por: Olsen, Ingar, et al.
Publicado: (2015)

Mechanisms of outer membrane vesicle entry into host cells
por: O'Donoghue, Eloise J., et al.
Publicado: (2016)

Bacterial outer membrane vesicles at the plant–pathogen interface
por: Katsir, Leron, et al.
Publicado: (2017)

Continuous production of Neisseria meningitidis outer membrane vesicles
por: Gerritzen, Matthias J.H., et al.
Publicado: (2019)

Outer Membrane Vesicle Induction and Isolation for Vaccine Development
por: Balhuizen, Melanie D., et al.
Publicado: (2021)

Bacterial Outer Membrane Vesicles as Antibiotic Delivery Vehicles
por: Collins, Shannon M., et al.
Publicado: (2021)

Shigella Outer Membrane Vesicles as Promising Targets for Vaccination
por: Qasim, Muhammad, et al.
Publicado: (2022)

Outer Membrane Vesicles as Mediators of Plant–Bacterial Interactions
por: Rudnicka, Małgorzata, et al.
Publicado: (2022)

Bacterial outer membrane vesicle-based cancer nanovaccines
por: Gao, Xiaoyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d7ogs8j9o6tg2noiphum3gcipf